Clinical Trials | September 01, 2022
Daiichi Sankyo announces initiation of Phase 3 Trial of mRNA
COVID-19 Vaccine (DS-5670) in Unvaccinated Individuals in Japan
COVID-19 Vaccine (DS-5670) in Unvaccinated Individuals in Japan
The existing hospital premises has the scope to further scale up the bed capacity as and when required in the future with minimal Capex.
It is high time that India assumed a leadership role in healthcare.
JB Pharma is the fastest growing pharmaceutical company in FY 2021-22 and Q1 of FY 2022-23.
3D CMOS chip for connecting electroactive tissues and organoids to software
The pandemic has taught us that health is not the exclusive responsibility of only the Union Health Ministry but jointly addressed by various Ministries at the centre and through state governments
The company is relieving all its staff who were directly engaged by our US subsidiary in its plant in connection with the manufacturing process in a phased manner
~96% decline reported in Malaria cases in Madhya Pradesh, due to public-private-people partnership
DEP® ADCs exploit the unique potential of Starpharma's DEP® technology to provide enhanced characteristics to ADCs i
The estimated capex is to the tune of Rs. 140 crore to be funded through debt and internal accrual
Subscribe To Our Newsletter & Stay Updated
